nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—CA5B—Hydrochlorothiazide—nephrolithiasis	0.199	0.24	CbGbCtD
Celecoxib—CA12—Hydrochlorothiazide—nephrolithiasis	0.171	0.206	CbGbCtD
Celecoxib—CA9—Hydrochlorothiazide—nephrolithiasis	0.171	0.206	CbGbCtD
Celecoxib—CA4—Hydrochlorothiazide—nephrolithiasis	0.15	0.181	CbGbCtD
Celecoxib—CA2—Hydrochlorothiazide—nephrolithiasis	0.138	0.167	CbGbCtD
Celecoxib—CA2—collecting duct of renal tubule—nephrolithiasis	0.00746	0.175	CbGeAlD
Celecoxib—CA4—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00548	0.149	CbGpPWpGaD
Celecoxib—CA2—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00525	0.142	CbGpPWpGaD
Celecoxib—Blood potassium increased—Hydrochlorothiazide—nephrolithiasis	0.00394	0.0435	CcSEcCtD
Celecoxib—PDPK1—nephron tubule—nephrolithiasis	0.00344	0.0805	CbGeAlD
Celecoxib—Stiffness—Hydrochlorothiazide—nephrolithiasis	0.00313	0.0346	CcSEcCtD
Celecoxib—PDPK1—renal system—nephrolithiasis	0.00313	0.0732	CbGeAlD
Celecoxib—PDPK1—kidney—nephrolithiasis	0.00302	0.0708	CbGeAlD
Celecoxib—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.00296	0.0801	CbGpPWpGaD
Celecoxib—PTGS2—nephron—nephrolithiasis	0.00245	0.0574	CbGeAlD
Celecoxib—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00243	0.0268	CcSEcCtD
Celecoxib—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00227	0.025	CcSEcCtD
Celecoxib—CYP2C9—urine—nephrolithiasis	0.00225	0.0527	CbGeAlD
Celecoxib—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.00176	0.0195	CcSEcCtD
Celecoxib—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00173	0.0191	CcSEcCtD
Celecoxib—CYP3A4—urine—nephrolithiasis	0.00172	0.0402	CbGeAlD
Celecoxib—CYP2D6—urine—nephrolithiasis	0.00169	0.0396	CbGeAlD
Celecoxib—MAPK14—renal system—nephrolithiasis	0.00167	0.0392	CbGeAlD
Celecoxib—MAPK14—kidney—nephrolithiasis	0.00162	0.0379	CbGeAlD
Celecoxib—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.00156	0.0172	CcSEcCtD
Celecoxib—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00156	0.0172	CcSEcCtD
Celecoxib—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00133	0.0147	CcSEcCtD
Celecoxib—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00132	0.0146	CcSEcCtD
Celecoxib—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00128	0.0142	CcSEcCtD
Celecoxib—CA12—renal system—nephrolithiasis	0.00127	0.0297	CbGeAlD
Celecoxib—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.00126	0.0139	CcSEcCtD
Celecoxib—CA12—kidney—nephrolithiasis	0.00123	0.0287	CbGeAlD
Celecoxib—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00122	0.0135	CcSEcCtD
Celecoxib—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00121	0.0134	CcSEcCtD
Celecoxib—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.00118	0.032	CbGpPWpGaD
Celecoxib—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00112	0.0124	CcSEcCtD
Celecoxib—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00112	0.0123	CcSEcCtD
Celecoxib—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00109	0.012	CcSEcCtD
Celecoxib—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00108	0.0119	CcSEcCtD
Celecoxib—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.000999	0.011	CcSEcCtD
Celecoxib—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.000994	0.011	CcSEcCtD
Celecoxib—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.000985	0.0109	CcSEcCtD
Celecoxib—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.000976	0.0108	CcSEcCtD
Celecoxib—ABCC4—nephron tubule—nephrolithiasis	0.00094	0.022	CbGeAlD
Celecoxib—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.000924	0.0102	CcSEcCtD
Celecoxib—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00092	0.0102	CcSEcCtD
Celecoxib—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.000916	0.0101	CcSEcCtD
Celecoxib—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.000916	0.0101	CcSEcCtD
Celecoxib—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.000868	0.00958	CcSEcCtD
Celecoxib—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.000865	0.00954	CcSEcCtD
Celecoxib—CA4—nephron tubule—nephrolithiasis	0.000864	0.0202	CbGeAlD
Celecoxib—ABCC4—renal system—nephrolithiasis	0.000855	0.02	CbGeAlD
Celecoxib—Migraine—Hydrochlorothiazide—nephrolithiasis	0.000851	0.00939	CcSEcCtD
Celecoxib—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.000835	0.00921	CcSEcCtD
Celecoxib—PDPK1—Signaling by Insulin receptor—ATP6V0A4—nephrolithiasis	0.000832	0.0226	CbGpPWpGaD
Celecoxib—ABCC4—kidney—nephrolithiasis	0.000826	0.0193	CbGeAlD
Celecoxib—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.000813	0.00897	CcSEcCtD
Celecoxib—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00081	0.00894	CcSEcCtD
Celecoxib—ABCC4—cortex of kidney—nephrolithiasis	0.000805	0.0188	CbGeAlD
Celecoxib—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.000798	0.00881	CcSEcCtD
Celecoxib—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.000793	0.00875	CcSEcCtD
Celecoxib—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00079	0.00871	CcSEcCtD
Celecoxib—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.000787	0.00868	CcSEcCtD
Celecoxib—CA4—renal system—nephrolithiasis	0.000786	0.0184	CbGeAlD
Celecoxib—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.000781	0.00862	CcSEcCtD
Celecoxib—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.000779	0.00859	CcSEcCtD
Celecoxib—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.000779	0.00859	CcSEcCtD
Celecoxib—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.000765	0.00844	CcSEcCtD
Celecoxib—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.000763	0.00842	CcSEcCtD
Celecoxib—CA4—kidney—nephrolithiasis	0.000759	0.0178	CbGeAlD
Celecoxib—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.000747	0.00825	CcSEcCtD
Celecoxib—CA4—cortex of kidney—nephrolithiasis	0.00074	0.0173	CbGeAlD
Celecoxib—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.000733	0.00809	CcSEcCtD
Celecoxib—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.000728	0.00803	CcSEcCtD
Celecoxib—CA2—nephron tubule—nephrolithiasis	0.000717	0.0168	CbGeAlD
Celecoxib—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.000699	0.00771	CcSEcCtD
Celecoxib—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.000695	0.00766	CcSEcCtD
Celecoxib—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00069	0.00762	CcSEcCtD
Celecoxib—MAPK14—Cell-Cell communication—CLDN14—nephrolithiasis	0.000687	0.0186	CbGpPWpGaD
Celecoxib—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.000682	0.00753	CcSEcCtD
Celecoxib—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00068	0.00751	CcSEcCtD
Celecoxib—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.000674	0.00744	CcSEcCtD
Celecoxib—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00067	0.0074	CcSEcCtD
Celecoxib—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.000661	0.00729	CcSEcCtD
Celecoxib—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.000657	0.00725	CcSEcCtD
Celecoxib—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.000653	0.00721	CcSEcCtD
Celecoxib—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.000653	0.00721	CcSEcCtD
Celecoxib—CA2—renal system—nephrolithiasis	0.000651	0.0153	CbGeAlD
Celecoxib—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.000649	0.00717	CcSEcCtD
Celecoxib—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.000648	0.00715	CcSEcCtD
Celecoxib—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.000648	0.00715	CcSEcCtD
Celecoxib—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.000635	0.00701	CcSEcCtD
Celecoxib—CA2—kidney—nephrolithiasis	0.00063	0.0147	CbGeAlD
Celecoxib—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.000628	0.00694	CcSEcCtD
Celecoxib—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.000625	0.0069	CcSEcCtD
Celecoxib—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.000622	0.00686	CcSEcCtD
Celecoxib—CA2—cortex of kidney—nephrolithiasis	0.000613	0.0144	CbGeAlD
Celecoxib—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0006	0.00662	CcSEcCtD
Celecoxib—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.000598	0.0066	CcSEcCtD
Celecoxib—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.000595	0.00657	CcSEcCtD
Celecoxib—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.000594	0.00655	CcSEcCtD
Celecoxib—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.000589	0.0065	CcSEcCtD
Celecoxib—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.000566	0.00624	CcSEcCtD
Celecoxib—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.000558	0.00615	CcSEcCtD
Celecoxib—Flushing—Hydrochlorothiazide—nephrolithiasis	0.000555	0.00613	CcSEcCtD
Celecoxib—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.000534	0.0059	CcSEcCtD
Celecoxib—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.000529	0.00583	CcSEcCtD
Celecoxib—MAPK14—Cell-Cell communication—CLDN16—nephrolithiasis	0.000521	0.0141	CbGpPWpGaD
Celecoxib—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.000513	0.00566	CcSEcCtD
Celecoxib—Tension—Hydrochlorothiazide—nephrolithiasis	0.000511	0.00564	CcSEcCtD
Celecoxib—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00051	0.00563	CcSEcCtD
Celecoxib—PDPK1—FGF signaling pathway—SPP1—nephrolithiasis	0.000509	0.0138	CbGpPWpGaD
Celecoxib—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.000506	0.00558	CcSEcCtD
Celecoxib—Back pain—Hydrochlorothiazide—nephrolithiasis	0.000504	0.00556	CcSEcCtD
Celecoxib—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.000501	0.00552	CcSEcCtD
Celecoxib—PDPK1—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.000497	0.0135	CbGpPWpGaD
Celecoxib—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.000491	0.00542	CcSEcCtD
Celecoxib—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.000481	0.00531	CcSEcCtD
Celecoxib—PTGS2—renal system—nephrolithiasis	0.000481	0.0113	CbGeAlD
Celecoxib—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.000476	0.00525	CcSEcCtD
Celecoxib—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.000468	0.00516	CcSEcCtD
Celecoxib—Syncope—Hydrochlorothiazide—nephrolithiasis	0.000467	0.00515	CcSEcCtD
Celecoxib—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.000466	0.00514	CcSEcCtD
Celecoxib—PTGS2—kidney—nephrolithiasis	0.000465	0.0109	CbGeAlD
Celecoxib—ABCC4—NRF2 pathway—SLC2A9—nephrolithiasis	0.000461	0.0125	CbGpPWpGaD
Celecoxib—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00046	0.00508	CcSEcCtD
Celecoxib—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.000458	0.00505	CcSEcCtD
Celecoxib—Cough—Hydrochlorothiazide—nephrolithiasis	0.000454	0.00501	CcSEcCtD
Celecoxib—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.000443	0.00489	CcSEcCtD
Celecoxib—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.000443	0.00489	CcSEcCtD
Celecoxib—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000443	0.00489	CcSEcCtD
Celecoxib—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.000442	0.00488	CcSEcCtD
Celecoxib—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000434	0.00478	CcSEcCtD
Celecoxib—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000428	0.00473	CcSEcCtD
Celecoxib—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000425	0.00469	CcSEcCtD
Celecoxib—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.000425	0.00469	CcSEcCtD
Celecoxib—CYP3A4—renal system—nephrolithiasis	0.00042	0.00984	CbGeAlD
Celecoxib—Shock—Hydrochlorothiazide—nephrolithiasis	0.000418	0.00461	CcSEcCtD
Celecoxib—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000416	0.00459	CcSEcCtD
Celecoxib—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.000415	0.00458	CcSEcCtD
Celecoxib—CYP2D6—renal system—nephrolithiasis	0.000414	0.00968	CbGeAlD
Celecoxib—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000411	0.00453	CcSEcCtD
Celecoxib—CYP3A4—kidney—nephrolithiasis	0.000406	0.00951	CbGeAlD
Celecoxib—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000405	0.00447	CcSEcCtD
Celecoxib—CYP2D6—kidney—nephrolithiasis	0.0004	0.00936	CbGeAlD
Celecoxib—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.000387	0.00427	CcSEcCtD
Celecoxib—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000384	0.00424	CcSEcCtD
Celecoxib—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000382	0.00421	CcSEcCtD
Celecoxib—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000379	0.00418	CcSEcCtD
Celecoxib—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000378	0.00417	CcSEcCtD
Celecoxib—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000374	0.00413	CcSEcCtD
Celecoxib—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000369	0.00408	CcSEcCtD
Celecoxib—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000366	0.00404	CcSEcCtD
Celecoxib—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000363	0.00401	CcSEcCtD
Celecoxib—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00035	0.00386	CcSEcCtD
Celecoxib—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000348	0.00383	CcSEcCtD
Celecoxib—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000338	0.00373	CcSEcCtD
Celecoxib—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000336	0.00371	CcSEcCtD
Celecoxib—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000336	0.00371	CcSEcCtD
Celecoxib—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000313	0.00346	CcSEcCtD
Celecoxib—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000305	0.00336	CcSEcCtD
Celecoxib—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000301	0.00332	CcSEcCtD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.000295	0.00799	CbGpPWpGaD
Celecoxib—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000291	0.00321	CcSEcCtD
Celecoxib—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000281	0.0031	CcSEcCtD
Celecoxib—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00027	0.00298	CcSEcCtD
Celecoxib—Rash—Hydrochlorothiazide—nephrolithiasis	0.000268	0.00296	CcSEcCtD
Celecoxib—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000268	0.00295	CcSEcCtD
Celecoxib—Headache—Hydrochlorothiazide—nephrolithiasis	0.000266	0.00294	CcSEcCtD
Celecoxib—MAPK14—FGF signaling pathway—SPP1—nephrolithiasis	0.000265	0.00717	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.000258	0.007	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000257	0.00697	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000257	0.00697	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—SLC7A9—nephrolithiasis	0.000256	0.00694	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—DGKH—nephrolithiasis	0.000256	0.00694	CbGpPWpGaD
Celecoxib—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000252	0.00279	CcSEcCtD
Celecoxib—CA14—Metabolism—GRHPR—nephrolithiasis	0.000244	0.00661	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00024	0.00649	CbGpPWpGaD
Celecoxib—CA6—Metabolism—GRHPR—nephrolithiasis	0.000238	0.00644	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—GRHPR—nephrolithiasis	0.000238	0.00644	CbGpPWpGaD
Celecoxib—PDPK1—BDNF signaling pathway—SPP1—nephrolithiasis	0.000232	0.0063	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000229	0.00621	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—GRHPR—nephrolithiasis	0.000222	0.00601	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—AQP1—nephrolithiasis	0.000218	0.0059	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—RGS14—nephrolithiasis	0.000218	0.0059	CbGpPWpGaD
Celecoxib—CA14—Metabolism—AGXT—nephrolithiasis	0.000217	0.00589	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—AGXT—nephrolithiasis	0.000212	0.00574	CbGpPWpGaD
Celecoxib—CA6—Metabolism—AGXT—nephrolithiasis	0.000212	0.00574	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00021	0.00568	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00021	0.00568	CbGpPWpGaD
Celecoxib—CA12—Metabolism—GRHPR—nephrolithiasis	0.000205	0.00557	CbGpPWpGaD
Celecoxib—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000204	0.00553	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—AGXT—nephrolithiasis	0.000198	0.00536	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by PDGF—SPP1—nephrolithiasis	0.000193	0.00522	CbGpPWpGaD
Celecoxib—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000187	0.00506	CbGpPWpGaD
Celecoxib—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000187	0.00506	CbGpPWpGaD
Celecoxib—PDPK1—Focal Adhesion—SPP1—nephrolithiasis	0.000186	0.00504	CbGpPWpGaD
Celecoxib—CA14—Metabolism—APRT—nephrolithiasis	0.000185	0.00501	CbGpPWpGaD
Celecoxib—CA14—Metabolism—SLC26A1—nephrolithiasis	0.000185	0.00501	CbGpPWpGaD
Celecoxib—CA12—Metabolism—AGXT—nephrolithiasis	0.000183	0.00496	CbGpPWpGaD
Celecoxib—CA6—Metabolism—APRT—nephrolithiasis	0.00018	0.00488	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—SLC26A1—nephrolithiasis	0.00018	0.00488	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—APRT—nephrolithiasis	0.00018	0.00488	CbGpPWpGaD
Celecoxib—CA6—Metabolism—SLC26A1—nephrolithiasis	0.00018	0.00488	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—SLC26A1—nephrolithiasis	0.000168	0.00456	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—APRT—nephrolithiasis	0.000168	0.00456	CbGpPWpGaD
Celecoxib—CA4—Metabolism—GRHPR—nephrolithiasis	0.000164	0.00444	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000162	0.00439	CbGpPWpGaD
Celecoxib—MAPK14—Toll-like Receptor Signaling Pathway—SPP1—nephrolithiasis	0.000159	0.00431	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000159	0.0043	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000159	0.0043	CbGpPWpGaD
Celecoxib—CA2—Metabolism—GRHPR—nephrolithiasis	0.000157	0.00426	CbGpPWpGaD
Celecoxib—CA12—Metabolism—APRT—nephrolithiasis	0.000156	0.00422	CbGpPWpGaD
Celecoxib—CA12—Metabolism—SLC26A1—nephrolithiasis	0.000156	0.00422	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—DGKH—nephrolithiasis	0.000152	0.00412	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—SLC7A9—nephrolithiasis	0.000152	0.00412	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ADCY10—nephrolithiasis	0.000151	0.0041	CbGpPWpGaD
Celecoxib—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.000151	0.00409	CbGpPWpGaD
Celecoxib—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.00015	0.00406	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000148	0.004	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000148	0.004	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—DGKH—nephrolithiasis	0.000147	0.00398	CbGpPWpGaD
Celecoxib—CA4—Metabolism—AGXT—nephrolithiasis	0.000146	0.00396	CbGpPWpGaD
Celecoxib—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000141	0.00383	CbGpPWpGaD
Celecoxib—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000141	0.00383	CbGpPWpGaD
Celecoxib—CA2—Metabolism—AGXT—nephrolithiasis	0.00014	0.00379	CbGpPWpGaD
Celecoxib—PDPK1—Disease—SLC26A1—nephrolithiasis	0.000139	0.00377	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.000133	0.00362	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—SLC7A9—nephrolithiasis	0.000133	0.00361	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—DGKH—nephrolithiasis	0.000133	0.00361	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GRHPR—nephrolithiasis	0.000132	0.00359	CbGpPWpGaD
Celecoxib—CA14—Metabolism—AQP1—nephrolithiasis	0.000132	0.00357	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000132	0.00357	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000132	0.00357	CbGpPWpGaD
Celecoxib—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000131	0.00356	CbGpPWpGaD
Celecoxib—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000131	0.00356	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—RGS14—nephrolithiasis	0.000129	0.00348	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—AQP1—nephrolithiasis	0.000128	0.00348	CbGpPWpGaD
Celecoxib—CA6—Metabolism—AQP1—nephrolithiasis	0.000128	0.00348	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—SPP1—nephrolithiasis	0.000124	0.00337	CbGpPWpGaD
Celecoxib—CA4—Metabolism—APRT—nephrolithiasis	0.000124	0.00337	CbGpPWpGaD
Celecoxib—CA4—Metabolism—SLC26A1—nephrolithiasis	0.000124	0.00337	CbGpPWpGaD
Celecoxib—PDPK1—Disease—ATP6V0A4—nephrolithiasis	0.000124	0.00336	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—SPP1—nephrolithiasis	0.000121	0.00327	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—AQP1—nephrolithiasis	0.00012	0.00325	CbGpPWpGaD
Celecoxib—CA2—Metabolism—SLC26A1—nephrolithiasis	0.000119	0.00323	CbGpPWpGaD
Celecoxib—CA14—Metabolism—CHRM3—nephrolithiasis	0.000119	0.00323	CbGpPWpGaD
Celecoxib—CA2—Metabolism—APRT—nephrolithiasis	0.000119	0.00323	CbGpPWpGaD
Celecoxib—CA9—Metabolism—AGXT—nephrolithiasis	0.000118	0.0032	CbGpPWpGaD
Celecoxib—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000117	0.00318	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000117	0.00317	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000116	0.00315	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000116	0.00315	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—CHRM3—nephrolithiasis	0.000116	0.00314	CbGpPWpGaD
Celecoxib—CA6—Metabolism—CHRM3—nephrolithiasis	0.000116	0.00314	CbGpPWpGaD
Celecoxib—CA12—Metabolism—AQP1—nephrolithiasis	0.000111	0.00301	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—CHRM3—nephrolithiasis	0.000108	0.00294	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—PTH—nephrolithiasis	0.000107	0.0029	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000106	0.00288	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000105	0.00285	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000104	0.00281	CbGpPWpGaD
Celecoxib—CA12—Metabolism—CHRM3—nephrolithiasis	0.0001	0.00272	CbGpPWpGaD
Celecoxib—CA9—Metabolism—SLC26A1—nephrolithiasis	0.0001	0.00272	CbGpPWpGaD
Celecoxib—CA9—Metabolism—APRT—nephrolithiasis	0.0001	0.00272	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	9.88e-05	0.00268	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—PTH—nephrolithiasis	9.72e-05	0.00263	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	9.48e-05	0.00257	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	9.48e-05	0.00257	CbGpPWpGaD
Celecoxib—CA4—Metabolism—AQP1—nephrolithiasis	8.85e-05	0.0024	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—DGKH—nephrolithiasis	8.68e-05	0.00235	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ATP6V0A4—nephrolithiasis	8.68e-05	0.00235	CbGpPWpGaD
Celecoxib—CA2—Metabolism—AQP1—nephrolithiasis	8.48e-05	0.0023	CbGpPWpGaD
Celecoxib—CA4—Metabolism—CHRM3—nephrolithiasis	8e-05	0.00217	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ADCY10—nephrolithiasis	7.85e-05	0.00213	CbGpPWpGaD
Celecoxib—CA2—Metabolism—CHRM3—nephrolithiasis	7.67e-05	0.00208	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	7.19e-05	0.00195	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	7.19e-05	0.00195	CbGpPWpGaD
Celecoxib—CA9—Metabolism—AQP1—nephrolithiasis	7.15e-05	0.00194	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—SLC7A9—nephrolithiasis	6.88e-05	0.00186	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—DGKH—nephrolithiasis	6.88e-05	0.00186	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	6.68e-05	0.00181	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	6.68e-05	0.00181	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RGS14—nephrolithiasis	6.68e-05	0.00181	CbGpPWpGaD
Celecoxib—CA9—Metabolism—CHRM3—nephrolithiasis	6.46e-05	0.00175	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CHRM3—nephrolithiasis	6.28e-05	0.0017	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	5.95e-05	0.00161	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	5.95e-05	0.00161	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PTH—nephrolithiasis	5.74e-05	0.00156	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GRHPR—nephrolithiasis	5.1e-05	0.00138	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	4.76e-05	0.00129	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SLC26A1—nephrolithiasis	4.62e-05	0.00125	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AGXT—nephrolithiasis	4.55e-05	0.00123	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.51e-05	0.00122	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—DGKH—nephrolithiasis	4.51e-05	0.00122	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GRHPR—nephrolithiasis	4.13e-05	0.00112	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ATP6V0A4—nephrolithiasis	4.12e-05	0.00112	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—SLC26A1—nephrolithiasis	3.87e-05	0.00105	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APRT—nephrolithiasis	3.87e-05	0.00105	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AGXT—nephrolithiasis	3.68e-05	0.000997	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GRHPR—nephrolithiasis	3.41e-05	0.000924	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GRHPR—nephrolithiasis	3.38e-05	0.000916	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CHRM3—nephrolithiasis	3.26e-05	0.000884	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APRT—nephrolithiasis	3.13e-05	0.000848	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SLC26A1—nephrolithiasis	3.13e-05	0.000848	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AGXT—nephrolithiasis	3.04e-05	0.000823	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AGXT—nephrolithiasis	3.01e-05	0.000816	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PTH—nephrolithiasis	2.98e-05	0.000809	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SPP1—nephrolithiasis	2.88e-05	0.000781	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AQP1—nephrolithiasis	2.76e-05	0.000747	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APRT—nephrolithiasis	2.58e-05	0.0007	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	2.58e-05	0.0007	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	2.56e-05	0.000694	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APRT—nephrolithiasis	2.56e-05	0.000694	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CHRM3—nephrolithiasis	2.49e-05	0.000675	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AQP1—nephrolithiasis	2.23e-05	0.000604	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GRHPR—nephrolithiasis	2.23e-05	0.000604	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CHRM3—nephrolithiasis	2.02e-05	0.000546	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AGXT—nephrolithiasis	1.99e-05	0.000538	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AQP1—nephrolithiasis	1.84e-05	0.000499	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AQP1—nephrolithiasis	1.82e-05	0.000495	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	1.69e-05	0.000458	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APRT—nephrolithiasis	1.69e-05	0.000458	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CHRM3—nephrolithiasis	1.66e-05	0.000451	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CHRM3—nephrolithiasis	1.65e-05	0.000447	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SPP1—nephrolithiasis	1.5e-05	0.000406	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AQP1—nephrolithiasis	1.2e-05	0.000326	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CHRM3—nephrolithiasis	1.09e-05	0.000295	CbGpPWpGaD
